BioSpace News Archive

Camurus announced that the US Food and Drug Administration has granted orphan drug designation for the company’s investigational medicinal product, octreotide subcutaneous depot, for the treatment of autosomal dominant polycystic liver disease.

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, announced that it has entered into a $50 million loan facility and security agreement with K2 HealthVentures.

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for cancer patients, is pleased to present an e-poster of results from a computational approach to optimizing therapeutic selection for cancer patients using the Company’s proprietary precision-oncology DELVE platform, at the European Society for Medical Oncology Virtual Congress 2021.

Hyperfine, Inc. is proud to announce that The Ohio State University Wexner Medical Center is deploying two Swoop™ systems in the emergency room, and the Comprehensive Stroke Center operating room.

Gilead Sciences, Inc. announced new data from the Phase 3 ASCENT study of Trodelvy® in patients with relapsed or refractory metastatic triple-negative breast cancer who received two or more prior systemic therapies, at least one of them for metastatic disease.

Gilead Sciences, Inc. announced new data from the Phase 3 ASCENT study evaluating Trodelvy® in patients with relapsed or refractory metastatic triple-negative breast cancer who received two or more prior systemic therapies, at least one of them for metastatic disease.

Bristol Myers Squibb announced that Opdivo plus Yervoy continued to demonstrate durable, long-term survival in the Phase 3 CheckMate -214 trial, with a five-year survival rate of 48% in patients with previously untreated advanced or metastatic renal cell carcinoma.

THINK Surgical, Inc., an innovator in the field of orthopedic robotic surgery, announced that St. Vincent Charity Medical Center in Cleveland is among the first healthcare facilities in the United States and the first healthcare facility in Ohio to utilize the second-generation TSolution One® Total Knee Application for total knee arthroplasty.

Apollo Medical Holdings, Inc. today announced that Brandon Sim , Chief Operating Officer and Chief Technology Officer, and Eric Chin, Chief Financial Officer, are scheduled to present at the 2021 Cantor Virtual Global Healthcare Conference on Wednesday, September 29, 2021, at 1:40 p.m.

DESTINY-Gastric06 Phase 2 Trial of ENHERTU ® Initiated in China in Patients with HER2 Positive Advanced Gastric Cancer